Bio-Rad Laboratories (NYSE:BIO.B) Stock Crosses Above 50-Day Moving Average – Time to Sell?

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $275.96 and traded as high as $304.15. Bio-Rad Laboratories shares last traded at $304.15, with a volume of 4 shares traded.

Bio-Rad Laboratories Price Performance

The company’s 50-day moving average price is $275.96 and its 200-day moving average price is $290.44. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.21 and a quick ratio of 2.37. The company has a market cap of $8.14 billion, a P/E ratio of 50.11 and a beta of 0.96.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.89 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a net margin of 6.52% and a return on equity of 3.56%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.